<DOC>
	<DOCNO>NCT01011413</DOCNO>
	<brief_summary>Clinical data suggest standard dose anti-HIV medication , efavirenz ( EFV ) , could reduce without compromise effectiveness . Lower drug dos could fewer side effect would make EFV affordable . The purpose study compare safety effectiveness , 96 week , standard ( 600mg ) versus reduce dose ( 400mg ) EFV control HIV part initial combination antiretroviral therapy .</brief_summary>
	<brief_title>Safety Efficacy Reduced Dose Efavirenz ( EFV ) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors ( N ( ) RTI ) Antiretroviral-naïve HIV-infected Individuals .</brief_title>
	<detailed_description>In international , multicenter trial , 630 HIV infect patient receive previous treatment HIV-infection enrol . Participants randomize equally ( 1:1 ) receive truvada ( tenofovir emtricitabine ) either standard reduce dose EFV . Neither study doctor participant know treatment participant receiving . Physical examination , laboratory analysis questionnaires perform 11 study visit screen , baseline ( Week 0 ) , Weeks 4 , 12 , 24 , 36 , 48 , 60 , 72 , 84 96 . The primary aim study compare treatment group proportion patient undetectable HIV viral load ( HIV RNA &lt; 200 copies/mL ) 48 week . Information immune function , drug adherence , resistance antiretrovirals , quality life , mental state HIV-related condition also collect . Blood sample collect future testing . Interim analyse perform first 125 participant treatment group reach week 24 participant reach week 24 . These interim analysis provide early check reduce dose EFV suppress HIV infection effectively standard dose EFV . A follow-up analysis perform participant reach week 96 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<criteria>HIV1 positive license diagnostic test age &gt; 16 year age ( minimum age determine local regulation legal requirement dictate ) 50 &lt; CD4 &lt; 500 cells/µL No prior AIDSdefining illness , use CDC 1993 case definition ( except pulmonary tuberculosis ) HIV RNA ≥1000 copies/mL prior exposure ART ( include short course ARVs prevent MTCT ) calculate creatinine clearance ( CLCr ) equal 50 mL/min ( CockcroftGault formula ) provision write informed consent . follow laboratory value : absolute neutrophil count ( ANC ) &lt; 500 cells/μL hemoglobin &lt; 7.0 g/dL platelet count &lt; 50,000 cells/μL AST and/or ALT &gt; 5 x ULN pregnant woman nurse mother active opportunistic malignant disease adequate control use immunomodulators within 30 day prior screen use prohibit medication current alcohol illicit substance use might adversely affect study participation</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>ART</keyword>
	<keyword>Efavirenz</keyword>
	<keyword>Dose reduction</keyword>
</DOC>